SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-012002
Filing Date
2024-05-02
Accepted
2024-05-02 16:39:15
Documents
2
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 form3-05022024_080503.html 3  
1 form3-05022024_080503.xml 3 1664
2 ex24-05022024_080504.htm EX-24 5668
  Complete submission text file 0001415889-24-012002.txt   8774
Mailing Address 535 BOYLSTON ST., 2ND FLOOR BOSTON MA 02116
Business Address
Namouni Fouad (Reporting) CIK: 0001815851 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 24909158

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)